HARIKA VEMULAPALLI: Open Payments
NPI 1063197390 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,944 in 161 payments from 18 companies in 2025. Trend: 2023 $33 · 2024 $1,924 · 2025 $2,944
Food & beverage: $2,831Education: $113
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $422 |
| Incyte Corporation | 13 | $399 |
| ABBVIE INC. | 37 | $398 |
| Janssen Biotech, Inc. | 16 | $351 |
| LEO Pharma Inc. | 8 | $247 |
| Amgen Inc. | 10 | $169 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $161 |
| PFIZER INC. | 9 | $161 |
| Galderma Laboratories, L.P. | 12 | $160 |
| UCB, Inc. | 7 | $131 |
Products named: OPZELURA, TREMFYA, COSENTYX, SKYRIZI, RINVOQ, OTEZLA, CIBINQO, ANZUPGO.
Industry payments across NY — which companies pay providers there.
